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High-throughput fabrication of hepatic cell
clusteroids with enhanced growth and
functionality for tissue engineering applications†
Anheng Wang, a Leigh A. Madden b and Vesselin N. Paunov *a
Culturing of cells as three-dimensional (3D) clusters can enhance in vitro tests for basic biological
research as well as for therapeutics development. Such 3D culture models, however, are often more
complicated, cumbersome and expensive than two-dimensional (2D) cultures. Current methods for the
preparation of tissue spheroids require complex materials, involve tedious facilities and are generally not
scalable. We report a novel inexpensive and up-scalable method for the preparation of large quantities
of viable cell clusters (clusteroids) of hepatocytes (Hep-G2). The method has a high throughput potential
and is based on an aqueous two-phase system (ATPS) of stable water-in-water (w/w) Pickering
emulsions, formed of dextran (DEX) drops and poly ethylene oxide (PEO) continuous phase stabilized
with whey protein particles. This system enabled the rapid fabrication of cell clusteroids from Hep-G2
cells. Here, the interfacial tension of the aqueous phase in the emulsion droplets, where the cells
partition preferentially, is used to wrap the cells in separate compartments, and then the droplets are
shrank by changing the balance of ATPS, thus rapidly driving the cells from larger and loosely packed
DEX drops to mostly spherical clusters. Cell–Cell adhesion was strongly promoted within the w/w
Pickering emulsion droplets which helped the formation of the 3D clusteroids. These were collected
after subsequent dilution of the emulsion with culture media. The collected hepatic clusteroids were
incorporated into an alginate hydrogel in media to study their proliferation and the cell function
compared with individual cells under the same conditions. Our results confirmed that urea and albumin
production, which are both linked to hepatocyte cell function, was strongly reinforced in the clusteroid
based tissues compared to the one formulated with individual cells. This methodology could potentially
extend the w/w emulsion cell clustering platform in tissue generation and preparation of large quantities
of organoids for drug tests and replacement of animal models.
1. Introduction
The liver is the major organ involved in the metabolism and
clearance of numerous xenobiotics. However, detoxification of
many of these xenobiotics can contribute to the impairment of
liver functionality resulting in injury.1 Understanding xenobiotic
safety is important to numerous industries such as pharma-
ceuticals, agrochemicals, industrial chemicals, and consumer
products, and therefore robust systems for xenobiotic assessment
are required, in particular, to support the early research phases of
product development.2 Adverse drug reactions (ADRs) represent a
considerable hindrance to the amelioration of novel therapeutics
with B21% of drug attrition attributed to toxicity during the
development process.3 ADRs are a major cause of liver injury and
are responsible for up to 7% of hospital admissions. Drug-
induced liver injury (DILI), one of the most common forms of
ADRs, is the main reason for the withdrawal of drugs from the
market.3–5 These reactions are complicated and often require
interactions between the multiplex of parenchymal hepatocytes
and non-parenchymal cells such as stellate cells (SCs), Kupffer
cells (KCs), liver sinusoidal endothelial cells (LSECs), etc. DILI
encompasses a vast spectrum of manifestations: the impairment
of mitochondrial function, inflammation and lethal effects of the
immune response, cell death via necrosis and apoptosis, and
pathologies including micro-vesicular steatosis and cholestasis.6
In vitro liver models that possess the capability to predict potential
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adverse liver manifestations are greatly valued in the pharma-
ceutical sector7 as well as other industries.
To expand the supply of available livers for transplant,
numerous surgical options have been pursued, including split
liver transplants and living-related partial donor procedures.8
In spite of these surgical advances and improvements in organ
allocation, organ shortages remain acute, suggesting that it is
unlikely that liver transplantation procedures alone will ever
meet the increasing demand. Therefore, cell-based therapies
have long-held promise as an alternative to organ transplanta-
tion. Biomedical researchers at present have several types of 3D
cell models at their disposal. One such model most resembling
native tissues is organotypic explants, a small piece of tissue
freshly dissected from experimental animals and maintained
in vitro.9 Tissue explants have been exploited in nearly all
biomedical research fields and probably will not be replaced
by other 3D culture models in the near future.
However, such a model faces major obstacles, such as
difficulty in obtaining specimens and ethical approval. In addition,
tissue explants are typically several millimetres in size, which
hampers nutrient transport to central regions and results in poor
tissue viability. In view of these problems, a 3D culture model that
is simple to prepare and on a scale of 100–500 mm would be
a useful practical alternative to tissue explants or drug testing
platforms. In order to control the size of individual spheroids,
hanging-drop culture10,11 and 3D culturing in microwells12 are
extensively used. Alternative techniques are based on micro-
rotational flow13 and the magneto-Archimedes effect14 to form
similarly sized tissue spheroids. The current methods for the
production of cellosomes15,16 could also potentially serve as a
possible route for the large scale production of desired cell
spheroids. Encapsulation of cells in such structures has also
been achieved using natural biopolymers like alginate, pectin,
agarose and chitosan.17 However, most of the current processes
for the generation of cell spheroids cannot be practically used for
tissue engineering as they are required to be produced on a large
scale. A new cheap and rapid technology is needed, capable of
high throughput spheroid production.
Aqueous two-phase systems (ATPS) have previously been used
to make tumouroids,12,18,19 mainly by distributing dextran-rich
drops (DEX) and tumour cells to a polyethylene glycol rich
aqueous medium (PEG). Isolated tumour cells have been cultured
into individual globules in these DEX drops and their response
to drug therapy has been further studied12,20–22 since higher
chemotherapeutic drug resistance has been observed when
globules manufactured using this technique are compared to
2D cultured globules.19 Previous techniques have produced effec-
tive tumour spheroids to study drug efficiency, however, the aim
of these studies is to create large spheroids that should essen-
tially have a necrotic core and cells proliferating on the surface of
the spheroid. However, in tissue engineering (TE) applications,
there are technical limits on the scalability of these methods in
the production of a large number of cell spheroids. Recently,
Das et al. reported a rapid, expandable technique for the produc-
tion of tissue globules from human embryonic kidney cells
(HEK293) by trapping them in w/w Pickering emulsion droplets.23,24
Their technique is based on the formation of w/w Pickering
emulsions, in which cells are efficiently distributed in emulsion
droplets. In their method, the interfacial tension of the aqueous
DEX phase in the droplets, where the cells partition preferen-
tially, is used to wrap the cells in separate compartments, and
then the droplets are shrank by changing the osmotic balance of
the two aqueous phases (ATP), thus rapidly driving the cells from
larger and loosely packed drops to mostly spherical cell clusters.
These are collected after the break down of the w/w emulsion by
subsequent dilution with a growth media.
Intending to generate cell clusters with enhanced function,
we developed further the method of Das et al.23 and Celik et al.24
for the preparation of hepatocyte cell clusters (clusteroids) using
w/w Pickering emulsions as templates and explored their for-
mulation in suitable hydrogel matrix for 3D tissue engineering of
the liver graft. 3D cell cultures of human adult hepatocyte cells
(Hep-G2) were used for the production of hepatocyte spheroids.
This methodology could be used as a blueprint to enable the
growth of patients’ liver cells and to fabricate autologous cell
clusteroids for potential clinical applications. Herein, the present
work was conducted to discuss the materials and techniques
used to control the size of the emulsion drop templates and the
average size of the resulting hepatocyte clusteroids. Our results
show that viable hepatocyte clusteroids can be easily produced
using this technique in large quantities. We demonstrate that the
clusteroids fabricated by our w/w Pickering emulsion templating
enable the hepatic cells to gain higher growth rate, which also
results in clearly enhanced albumin and urea production.
2. Materials and methods
2.1 Materials
Deionized water purified by reverse osmosis and ion exchange
using a Milli-Q water system (Millipore) was used in all our
studies. Dextran (MW 500 kDa) and PEO (MW 200 kDa) were
both purchased from Sigma-Aldrich. Whey protein was sourced
from No1. Supplements, Suffolk, UK. Fluorescein diacetate
(FDA, 98%) and sodium alginate and Cornings Transwells
polyester membrane cell culture inserts (12 mm, 12 well plates)
were purchased from Sigma-Aldrich, UK. Sodium chloride
(99.8%) and calcium chloride were purchased from Fisher
Scientific. Eagle’s Modified Eagle Medium (EMEM) and
Trypsin–EDTA were sourced from Gibcos, Fisher Scientific.
NUNC Cell culture 24-well plates were purchased from Thermo
Fisher Scientific. Urea and albumin ELISA kit were purchased
from Sigma-Aldrich. Fetal bovine serum (FBS, Labtech, Heath-
field, UK) 0.25% Trypsin–EDTA (1X, Lonza). Alginate lyase was
purchased from Sigma Aldrich. All other chemicals were of
analytical grade.
2.2 2D Hep-G2 cell culture
Hep-G2 cell line culture was purchased from Public Health
England (PHE, Culture collection 85011430 Hep G2) cultured from
growing cells. The cells were cultured in EMEM media supple-
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After reaching 80% confluence, Hep-G2 cells were carefully washed
with phosphate buffer saline (PBS, Labtech, UK) for 10 s and then
incubated with 0.25% Trypsin–EDTA (1X, Lonza, UK), which
allowed us to detach the cells from their support after 5 min. Its
action was neutralized by adding complete EMEM medium before
centrifugation at 400  g for 4 min. After resuspension in fresh
medium, the Hep-G2 cells were reseeded in tissue culture flasks
(Sarstedt, UK).
2.3 Preparation of whey protein (WP) particles
Whey protein powder was dissolved in water at a concentration
of 2 wt% for 2 h under agitation. The solution was placed at
4 1C for 12 h to fully hydrate the whey protein. Then, the
solution was centrifuged at 10 800  g for 1 h and the super-
natant was collected. A solution of 300 mM NaCl was prepared
and mixed with an equal volume of WP solution. The pH was
adjusted to the required value by drop-wise addition of filtered
0.5 M HCl aqueous solution. After heating the WP/NaCl
solution in an oil bath at 85 1C for 15 min, it was left to cool
at 4 1C. This precipitation process produced WP particles,
which were used in our protocol as stabilizers for the water-
in-water Pickering emulsions.
2.4 Production of hepatic cell clusteroids
The cell clusteroid fabrication process was somewhat similar to
the procedure described in ref. 23 and 24. Briefly, PEO aqueous
solution (5.5 wt%) was prepared by dissolving PEO into the
heat-treated solution of WP, which constituted the continuous
phase of the water-in-water emulsion. Centrifugation of the
PEO solution was done beforehand at 5000  g for 7 min to
remove the silica nanoparticles from the PEO solution, which
have been added by the manufacturer. A solution of 5.5 wt%
dextran (in total) in EMEM complete medium under sterile
conditions was used as a disperse phase (DEX phase) together
with the Hep-G2 cells. The DEX phase with the hepatocytes
formed different volume fractions with respect to the DEX/PEO
w/w emulsion. To form the latter, the DEX phase was mixed
with the pelleted cells and then was transferred to the WP/NaCl/
PEO solution, and gently homogenized using two pumps with a
BD Microlancet 3, 6 or 12 needles (21G 12, internal diameter
0.512 mm) and a BD Plastipakt syringe of 5 mL using two pumps
(BD biosciences, Wokingham, UK). The w/w emulsion was pre-
pared using PEO and DEX phases at various volume fractions of
the two phases. The emulsion was further mixed with an aliquot
of PEO solution of higher concentration (14 wt% PEO) to reach a
total concentration of 10% in order to osmotically squeeze the
DEX droplets with the cells into densely packed clusteroids.
The cell clusters were left in the emulsion for 2 h to achieve
better cell–cell adhesion and stick together. The emulsion would
then be broken down by adding ten times higher volume of
EMEM medium, and the cell clusteroids were settled by gravity-
driven sedimentation.25
2.5 3D hepatocyte clusteroids culture
An aqueous solution of 2 wt% sodium alginate was prepared
and then sterilized in an autoclave. EMEM complete medium
was mixed with the 2 wt% sodium alginate solution at different
volumes to vary the gelling agent overall concentration. Hep-G2
cell clusteroids were then carefully resuspended in this solution
and seeded on 24-well tissue culture plates. The addition of
2 wt% CaCl2 (aq) allowed the crosslinking of the alginate chains
in the media and formation of a hydrogel. After 2 min
of incubation, the CaCl2 solution was carefully pipetted out
without compromising the integrity of the hydrogel–clusteroid
composite and the wells were topped up with EMEM medium.
The Ca2+ ions were used for the crosslinking of the alginate
hydrogel. The excess CaCl2 solution was removed after the
hydrogel formation. The crosslinking process takes no
longer than 2 min which had a very marginal impact on the
embedded cells.
2.6 Optical microscopy
The microstructure of w/w Pickering emulsion at different fDEX
ratios and the resulting clusteroids at different forms were first
analyzed using a fluorescence microscope (Olympus BX51), and
samples were observed under various water immersion objec-
tives at ambient temperature (25 1C). Briefly, 30 mL dispersions
were shifted and spread onto the hollow glass slide, which was
then enclosed by the glass cover.
2.7 WP particle size distribution measurement
The WP particle size was measured after diluting (100) the
samples with purified water to an appropriate particle concen-
tration using the Zetasizer Nano ZS (Malvern Instruments Ltd.,
Malvern, Worcestershire, UK) and Malvern MasterSizer 3000.
All measurements were carried out at room temperature and
the reported results were the averages of three readings.
2.8 Cell viability assay
Cell clusteroids were treated with a 5 g L1 solution of fluor-
escein diacetate (FDA, from Sigma-Aldrich) in acetone (10 mL of
solution per 1 mL of the dispersion of re-suspended clusteroids)
to evaluate cell viability. After 10 min of incubation at room
temperature in the dark, the sample was observed using an
Olympus BX-51 fluorescence microscope (Olympus) with a DP70
digital camera and FITC fluorescence filter set. FDA is known to
diffuse through cell membranes and only viable cells are able to
hydrolyze non-fluorescent FDA internally to fluorescein by intra-
cellular esterases. Since fluorescein dissociates in water, its cross-
ing of the cell membranes is hindered by its ionic charge, which
results in the accumulation of the fluorescent byproduct inside
the intact cells.23,24 This indicates that the cell membranes are
intact and the cells are viable.
2.9 Urea and albumin production assays
Urea concentration in the samples was quantified using a
colorimetric endpoint assay based on acid- and heat-catalyzed
condensation of urea with diacetylmonoxime (Stanbio Labs).
100 mL cell culture medium was collected and homogenized
with urea assay buffer and analyzed according to the manu-
facturer’s protocol. Due to the possible interference of the




























































































Mater. Adv. This journal is©The Royal Society of Chemistry 2020
after the sample was de-gelled. Briefly, 1 mL of 5 mg mL1
alginate lyase was added to each well followed by 30 min
incubation at 37 1C. Albumin content in the de-gelled media
was measured using an enzyme-linked immunosorbent assay
(ELISA) with horseradish peroxidase detection and peroxidase
substrate 3,3,5,5-tetramethylbenzidine as described according
to the manufacturer’s protocol. The absorbance (450 nm) of the
samples was determined using a Synergy HT plate reader and
values were quantified from a standard curve. Samples were
collected after 72 h of the initial cell seeding from 2D cultures.
Changing the culture media every day was essential for optimal
growth in 3D cultures and so 24 h cumulative albumin secre-
tion was measured at days 1, 2, 3, 4, 5, 6 and 7.
2.10 Cryo-SEM imaging
Cryo-scanning electron microscopy (Cryo-SEM) images of the
clusteroids were taken in order to reveal their morphology.
Samples were prepared for Cryo-SEM imaging after fixing the
cell clusteroids to avoid them breaking apart during the eva-
poration of the aqueous solution. 1 mL aliquots of the Hep-G2
cell clusteroids in media were deposited on dry Aclart sheets
(Agar Scientific Ltd, Essex, UK) or poly-lysine coated glass
coverslips and treated with 2 wt% glutaraldehyde for 1 h,
washed multiple times with Mill-Q water and subjected to
critical point drying. The samples were then imaged using a
Cryo-scanning electron microscope SEM (ZEISS EVO 60 EP-
SEM).
2.11 Statistical analysis
Comparisons were made using unpaired t-tests or analysis of
variance as appropriate with significance set at p r 0.05.
2.12 Crystal Violet staining
The 96-well plates were stained with Crystal Violet (CV) by
adding 130 mL to each cell. The 96-well plates were then
incubated for 30 min at room temperature and then rinsed 3
times by gentle submersion in water and allowed to dry over-
night. After the wells were fully dried, the CV was solubilised by
adding 125 mL from a stock solution of 30% acetic acid in
deionized water to each cell in the 96-well plates. The solubi-
lised CV solution was then transferred to new 96-well plates and
absorbance readings were taken using the Bio-Tek Synergyt HT
Multi-Detection Microplate Reader at 550 nm. The 30% stock
solution of acetic acid was used as a blank. The absorbance
readings were then normalised.
3. Results and discussion
3.1 WP particle characterization
Previous studies showed that emulsions made from preheated
and aggregated proteins were more stable than the ones with
native proteins.26–28 The heat-treatment allows them to make
protein aggregates that would stronger adsorb at the interface
between the continuous and dispersed aqueous phases.
The whey protein particles are a biocompatible stabilizer of
the w/w Pickering emulsions. They are a very essential compo-
nent in preventing DEX droplets dispersed in the PEO phase
from coalescing which leads to emulsion breakdown. The
absence of protein particles leads to phase separation in a very
short time and due to poor emulsion stability.24,28,29 This
makes the results without a particle stabilizer poorly reprodu-
cible. In the presence of the whey protein particles, the w/w
Pickering emulsions (DEX-in-PEO) had sufficient stability
which allowed us to handle the cell-loaded emulsions over
the selected time interval and produce cell clusteroids of
reproducible average size. Indeed, protein particles with a
radius higher than 85 nm have been found to increase droplet
size.28 WP particles produced by our methodology were char-
acterized before using them to stabilize the w/w Pickering
emulsions. Fig. 2 shows a typical size distribution of the WP
particles at different pH. The WP particles showed that the
most homogenous peak was at pH 6.18 with an average particle
size of 130  30 nm. Consequently, pH 6.18 was chosen for the
preparation of WP particles used in the following experiments.
In our experiments, stable DEX-in-PEO emulsions did not
form without the WP particle stabilizers. Thorough research of
the DEX/PEO aqueous two phase system stabilized by other
protein particles without cell encapsulation has been con-
ducted by Balakrishnan et al.33 These systems show strong
stability and could last for days. However, water-in-water Pick-
ering emulsions without cells are irrelevant to this study and
behave differently to those with cells.
3.2 Water-in-water emulsion characterization
In order to control the size of the DEX droplets, Pickering w/w
emulsions of different volume fractions of the DEX phase were
produced: f = 0.1, 0.11, 0.125, 0.14, 0.17, 0.2, 0.25, 0.33 and 0.5.
The images shown in Fig. 3 demonstrate that the variation of
the DEX phase volume has a strong impact on the emulsion
droplet size. The average size of the DEX emulsion droplets
with fDEX = 0.5 was about 80 mm, with a sharp decrease to 5 mm
when the fDEX decreased to 0.14. After the shrinking stage, the
DEX droplets (without any cells) had a similar size distribution
around 5 mm at any f ratio, which demonstrates the strong
effect of the osmotic pressure driven by the addition of high
concentration PEO solution (Fig. 4). Hence, decreasing the
volume fraction of the DEX phase resulted in smaller DEX
droplets with the decreased capacity for encapsulating a lower
number of cells. The microscopy observation of DEX droplets
shown in Fig. 3, showed that the water-in-water emulsions
contain a higher drop size with fDEX = 0.2 and 0.17. Conse-
quently, fDEX = 0.2 was selected for use in our production of
hepatocyte clusteroids in this research.
3.3 Effect of the hepatic cells’ encapsulation on the average
drop size of the w/w Pickering emulsion
For the sake of optimization and potential control of the
clusteroids formation, the effect of the cell encapsulation on
w/w Pickering emulsion drop size was further characterized. To
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were mixed with a DEX-based solution made with EMEM
media. The resulting mixture was added to the PEO-based
solution, followed by gentle mixing using a syringe as described
earlier. One can see from Fig. 5 and 6 that the cells packed in
the DEX droplets slightly increased the DEX droplet diameter.
Meanwhile, there remain cavities where the DEX droplets had
not fully shrank; in stark contrast, the clusteroids were densely
packaged in DEX droplets after the contraction. The scale of the
contraction is about 25%, from a diameter of 35 mm to 24 mm.
Hence the effect of the osmotic pressure is strong enough to
reduce the drop size and their interfacial tension to compress
the encapsulated cells into spherical clusters, thus increasing
their natural cell–cell adhesion as they gain more contact area
with each other.
3.4 Cell clusteroid formation in DEX-in-PEO emulsions
Three-dimensional cultures of tumour cells have recently
gained increasing interest in cancer research. These spheroids
are three-dimensional clusters of tumour cells that mimic
various properties of solid tumours and present a relevant
tumour model for drug discovery.11,29–31
The dependence of the cell spheroid’s size on the volume
fraction of DEX/PEO has been studied before by Celik et al.23
for HaCaT cells. Their results show that the spheroid’s size
depends not only on the DEX/PEO ratio but also on the cell
concentration in the APTS system. Given the complexity of
such phase diagram and the dependence of the obtained
spheroid’s size on the cell type and concentration, it was
not practical to scan the whole range of parameters. The
clusteroid’s size is also sensitive to the osmotic shrinking
procedure, i.e. the addition of the concentrated PEO phase.
Therefore, we adopted the optimized protocol by Celik et al.23
for the preparation of clusteroids with hepatic cells and the
current focus of this work is to demonstrate the enhanced
functionality of clusters.
To demonstrate the efficiency of the cell encapsulation, we
performed a spheroid assay using ATPS system made with PEO
(MW 35 kDa)–DEX (MW 500 kDa) solutions. A suspension of
Hep-G2 cells was generated, and this suspension was dispensed
and mixed with PEG phase solution. Because the density of
cells was between that of the DEX and the PEO solution, the
cells accumulated at the interface of the two phases after 1 h,
Fig. 2 The distribution of the hydrodynamic diameter of the produced
WP particles at different pH.
Fig. 1 Schematics of our high-throughput method for the preparation of hepatocyte cell clusteroids (A–D) and 3D tissue culturing (D–F) with
characterization (G and H). The hepatocyte cells are encapsulated in a dextran-PEO water-in-water emulsion template stabilized by 2 wt% whey protein
(WP) particles. The continuous phase is PEO 5.5 wt% and the dispersed phase is composed of cells encapsulated in 5.5% dextran droplets. Upon
emulsification, the cells prefer the discontinuous dextran phase, which allows their encapsulation. Adding a more concentrated PEO phase causes
osmotic shrinking of the cell-rich dextran drops, whose interfacial tension packs the cells into tissue clusteroids. The latter are isolated by breaking the
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as shown in Fig. S2 (ESI†). The collected clusteroids were
imaged using the microscope, as shown in Fig. 7, and seem
Fig. 3 Optical microscopy images of a DEX/PEO water-in-water Pickering emulsion (PEO 5.5 wt% and DEX 5.5 wt%). (A) fDEX = 0.5, (B) fDEX = 0.33,
(C) fDEX = 0.25, (D) fDEX = 0.2 (E), fDEX = 0.17 (F), fDEX = 0.14, (G) fDEX = 0.125, (H) fDEX = 0.11 and (I) fDEX = 0.1, stabilized by 2 wt% WP particles at
pH 6.18. Scale bars are 100 mm.
Fig. 4 Average DEX droplet diameter for the DEX/PEO Pickering emul-
sion produced from WP/NaCl 300 mM solution at pH 6.18, 5.5 wt% PEO/
5.5 wt% dextran for varying volume fractions of the DEX phase (average of
200–300 individual drops). The average drop diameters are represented
before shrinking (green bars) and after shrinking (blue bars). The data were
obtained by optical microscopy measurements of the DEX droplets for
each micrograph with ImageJ software. Fig. 5 Average DEX droplet diameter for the DEX/PEO Pickering emulsion
produced from WP/the average diameter of Hep-G2 cell clusteroids and
drops with encapsulated hepatic cells. The data were obtained by optical
microscopy measurements of 100–200 individual clusteroids for each
micrograph with ImageJ Software (Student’s t-test, NS: non-significant,
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compatible in structure and relatively uniform in size, at about
20 mm. The osmotic pressure compacted the cells in a spherical
shape and makes them have better cell–cell adhesion, which
helps the formation of the clusteroids.
Our results showed that Hep-G2 cells can form compact
clusteroids within 1 h of incubation in the w/w emulsions.
Therefore, we evaluated spheroid formation with all four two-
phase solutions after 1 h. Next, we examined the viability of
the longer-term culture. Viability of samples of the hepatic
cell spheroids and the single cells was initially tested using
the FDA live/dead assay before being added to the gel. One can
see from Fig. 8 that the viability of the individual (single) cell
and the one in the clusteroids are both high. This demon-
strates that the viability of the cells in the clusteroids is not
affected by our preparation method. These results combined
with the data obtained with water-in-water emulsion showed
that fDEX= 0.2 and 10 wt% PEO as a DEX drop shrinking
concentration are suitable for the preparation of Hep-G2 cell
clusteroids and this does not impair their further growth. This
composition was used for the following study.
Fig. 6 Optical microscopy images of (A, B, E, F) Hep-G2 cell-loaded DEX/PEO emulsion droplets (before shrinkage) and (C, D, G H) Hep-G2 cell
clusteroids obtained (after shrinkage of the DEX phase). The initial w/w emulsion was stabilized by 2 wt% WP particles with 5.5 wt% PEO/5.5 wt% Dextran.
Here the DEX volume fraction is fDEX = 0.2. Scale bars are 100 mm for (A, B, E, F) and 50 mm for (C, D, G, H).
Fig. 7 Optical microscopy images of Hep-G2 cell droplets encapsulated in the DEX/PEO water-in-water emulsions after shrinkage stabilized by 2 wt%




























































































Mater. Adv. This journal is©The Royal Society of Chemistry 2020
3.5 Hepatic clusteroid growth during long-term culture
We examined the compatibility of the assay with longer-term
culture. Clusteroids of two different cell densities of 1  106 to
1  105 mL1 were generated within 50 mL DEX drops
immersed in the PEO phase and then put into alginate hydrogel
fortified by 1 M CaCl2 treatment as described earlier. Each
condition was set with 12 replicates, that is, half of a 24-well
plate. After every 24 hours of growing the clusteroids within
each well, we added 1 mL of the same growth medium to the
wells after withdrawal of the same amount of old medium.
Therefore, the collected urea and albumin produced by the
clusteroids each day was removed from culture, and not
accumulated. Clusteroids were imaged every other day. Fig. 9
contains images showing that after three days of their growth,
the cells change from a cluster of individual cells to thicker,
globular structures. The clusteroids percolated throughout
the hydrogel to make contacts with cells from neighbouring
clustered cells after 5 days of culturing. We were unable to
further monitor the clusteroids’ diameter beyond seven days
due to the percolation of the hepatocyte clusteroids and the
formation of denser tissues (see Fig. 9).
As shown in Fig. 9, the growing mode of single cells and
clustered cells is completely different. The single cells proli-
ferated individually and would not form a cluster or spheroid
Fig. 8 (A and C) Optical bright-field microscopy images and (B and D) fluorescence microscopy images of single Hep-G2 cells after being treated with
the FDA live/dead assay. (E and G) Optical bright-field images and (F and H) fluorescence microscopy images (F and H) of Hep-g2 cell clusteroids treated
with 1 mM FDA. FDA treatment was done after the cell clusteroid fabrication. Green fluorescence indicates that both the Hep-G2 cells preserve their
viability during the clusteroid fabrication process (Fig. 1). The scale bar is 100 mm.
Fig. 9 Bright-field optical microscopy images of (A, B, C, D) monolayer cultured single Hep-G2 cells (E, F, G, H) Hep-G2 clusteroids isolated by dilution
of the DEX/PEO emulsion by a factor of 3 with EMEM medium and incorporated with 1 wt% sodium alginate in EMEM media followed by cross-linking
with 1M CaCl2. The Hep-G2 cell clusteroids were cultured in the alginate film for seven days in EMEM media and images were taken from each well to
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structure. In contrast, the clusteroids we imaged in the alginate
gels grew to form a compact tissue structure. The result clearly
shows that the alginate hydrogel does not provide a suitable
environment for clusteroid formation. The clusteroid for-
mation in our experiments is the result of the directed templating
of the w/w Pickering emulsion droplets on the embedded cells.
This result indicates that our technique can make the clustered
cells grow in the pattern in which the cell would proliferate
surrounding the initial core.
The clusteroids’ size was measured manually using ImageJ
software as the cell clusteroids continued growing in the seven
day culture (Fig. 10A). The cell size increased strongly in the
first three days, from 24 mm to 41 mm, and then increased
slowly to 55 mm in the following 4 days, which could be
attributed to the larger number of cells required to enlarge
the cell clusteroids. Here we aimed at using the produced
clusteroids in tissue engineering applications which requires
a high yield of clusteroids instead of absolute size uniformity.
The clusteroid uniformity is essential when using them for
drug testing. For growth monitoring, the clusteroids with lower
cell numbers of 1  105 mL1 were also put in the alginate gels
to observe the individual clusteroid growth.
In order to examine the viability of the clusteroids, samples
were taken out from the alginate gel by adding 5 mg mL1
alginate lyase solution. The viability of the cells in the clusteroids
was characterized on different days. The cells’ viability decreased
over a few days of culture, from 78% to 65% (Fig. 10B). This
might be the result of necrotic core formation when the clusters
become larger. The microscopic observations of the FDA treated
clusteroids after various days are shown in Fig. S3 (ESI†).
One can see from Fig. S4 (ESI†), that after 3 days of culture in
a hydrogel, the cell clusteroids became dense and compact.
A single Hep-G2 clusteroid could reach up to 80 mm after seven
days’ culture. SEM images of samples of such grafts after freeze-
drying at a critical point are shown at different resolutions in
Fig. 11. The clustering of the clusteroids in the hydrogel matrix
and the way they have started to spread out and percolate in the
gel should be noted. This process led to the formation of
integral tissues over the course of seven days. Interestingly,
Fig. 10 Evolution of the Hep-G2 clusteroids embedded in a hydrogel
composed at different days of culture. (A) The spheroid size vs. time and
(B) viability vs. time. Measurements of the clusteroids were taken every day
with ImageJ software by taking the average of the vertical and horizontal
diameter of 500 clusteroids in each well. (**p o 0.01,***p o 0.001).
Fig. 11 SEM images of a sample of Hep-G2 cell clusteroids encapsulated
in sodium alginate gels after 7 days of culture, deposited on a glass
substrate and freeze-dried before imaging. (A–C) Images correspond to
different resolutions. Note that the size of the clusteroids of cells is slightly
lower than the original cell clusteroids due to shrinkage. The bars are (A)
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the cell clusteroids had a relatively uniform size. The clusteroids
form a dense layer which is highly desirable for tissue engineering
applications.
3.6 Cell clusteroids liver-specific functionality
Cell polarity and ECM signalling have been shown to promote
liver-specific functions such as albumin secretion and meta-
bolic enzyme expression.32 To study the liver-specific functions
of the clustered Hep-G2 cells, albumin secretion and urea
synthesis by 1  106 of HepG2 cells pre-clustered in clusteroids,
cultured in series of 1 wt% sodium alginate gel, were quanti-
fied. Urea synthesis was quantified over 7 days of culture.
Fig. 12A shows the amount of albumin secreted into the
medium per day in each well after fixed number of days of
accumulation. A trend was found for cells cultured with gels:
the albumin secretion increases with longer culturing. In
alginate gel cultured with single cells, albumin secretion was
slightly higher than the gels encapsulated with clustered cells
at day 1. The result shown in Fig. S5 (ESI†) could also demon-
strate that the albumin production increased for every 24 h in
culture. On day 10, the amount of albumin secreted by Hep-G2
clustered cells was approximately three times higher than that
of similar number of individual Hep-G2 cells. The result
suggests that albumin secretion of the cells is improved in
clusteroids. Urea synthesis is another important liver-specific
function of Hep-G2 cells. The urea production profile of the
cells was similar to that for albumin secretion. As shown in
Fig. 12B, after 7 days of culture, urea synthesis by the accumu-
lation of both the individual cells and clusteroids increases
with time, but the urea production per day was continuously
decreasing for the seven days as shown in Fig. S5B (ESI†).
This could be attributed to the reduction of mesothelial cells
with the cell proliferation, which accounts for urea production.2
In addition, the urea synthesis rate by the clusteroids was two
times higher than the single cells, confirming again that the
introduction of clusteroids enhances the liver-specific functions of
the Hep-G2 cells. The result indicates that the cell–cell inter-
actions in these clusteroids benefit their high level of liver-specific
functions as revealed in Fig. 12.
4. Conclusions
3D cultures of tumor cells as spheroids present a physio-
logically relevant in vitro model that captures some key features
of solid tumors and could prove to be an essential tool for
compound screening to identify potent anti-cancer drugs.
Despite these recognized advantages, spheroids remain under-
utilized in high throughput screening applications due to the
limitations of the existing preparation techniques. We present
a new approach for the 3D culture of hepatic tumor cells
(Hep-G2) using immiscible aqueous solutions of two biopolymers,
dextran and PEO. We show that water-in-water Pickering emulsion
droplets of the dextran aqueous phase containing the Hep-G2 cells
encapsulate the cells and can facilitate the cell aggregation and
formation of compact cell spheroids by increasing the osmotic
pressure of the continuous phase of PEO solution. This was done
by adding more PEO to the continuous phase after the emulsion is
formed. The cell clusters that are obtained from each DEX drop
after osmotic shrinking with PEO were harvested after breaking
down the emulsion by dilution with culture media. This approach
allows the formation of consistent tissues in standard 24-well
plates, containing thousands of spheroids, to allow further bio-
chemical assays of cell responses in situ using plate readers.
We incorporated the hepatic cell clusteroids in alginate gel and
followed their growth over a course of up to 7 days compared with
the same number of single cells under the same conditions. The
liver-specific function of the hepatocytes was greatly enhanced due
to the formation of cell clusteroids. This is an essential feature for
application in tissue engineering as the same initial number of
cells grow faster, as well as for efficient high throughput screening
applications or further drug testing platforms. This approach to the
3D culture of hepatic cells will benefit a broad range of applications
in tissue engineering and drug library screening without a need for
special plates, devices, and facilities.
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